Visualitzant - Articles científics per títol

Observational study on fluid therapy management in surgical adult patients

Colomina, Maria Jose; Ripollés‑Melchor, Javier; Guilabert Sanz, Patricia; Jover Pinillos, Jose Luis; Basora, M.; Cassinello, Concepción (BMC, 2021-12-13)

Occupational radiation exposure of electrophysiology staff with reproductive potential and during pregnancy: an EHRA survey

Adeliño, Raquel; Malaczynska-Rajpold, Katarzyna; Perrotta, Laura; Manninger, Martin; Vanduynhoven, Philippe; Nesti, Martina (Oxford University Press, 2023-08-02)

Ocrelizumab exposure in relapsing–remitting multiple sclerosis: 10-year analysis of the phase 2 randomized clinical trial and its extension

Kappos, Ludwig; Li, David K B; Bar-Or, Amit; Barkhof, Frederik; Traboulsee, Anthony; Montalban, Xavier (Springer, 2024-02)

Off-Label Use of Rituximab in Patients with Different Types of Nephropathies in a Tertiary Hospital: A Retrospective Study

Sans Pola, Carla; Agustí Escasany, Maria Antònia; Bosch Gil, José Ángel; Agraz Pamplona, Irene; Alerany Pardo, Carme; Danes Carreras, Immaculada (MDPI, 2021-10-26)

Off-label use of rituximab in patients with systemic lupus erythematosus with extrarenal disease activity: a retrospective study and literature review

Sans-Pola, Carla; Danés Carreras, Immaculada; Bosch, Josep Àngel; Marrero Álvarez, Patricia; Cortes Hernandez, Josefina; Agustí, Antònia (Frontiers Media, 2023-05-25)

Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study)

Perez-Fidalgo, J. A.; Cortés, A.; Guerra, Eva; García, Y.; Iglesias, M.; Bohn Sarmiento, U.; Oaknin Benzaquen, Ana Mazaltob (Elsevier, 2021-08)

Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis

Poveda, Andres; Lheureux, S.; Cibula, David; Weberpals, J.; Oaknin Benzaquen, Ana Mazaltob; Colombo, Nicoletta; Lindemann, Kristina (Elsevier, 2022-03)

Old zoonotic agents and novel variants of tick-borne microorganisms from Benguela (Angola), July 2017

Palomar, Ana M.; Bocanegra García, Maria Cristina; Portillo, Aránzazu; Salvador Velez, Fernando M; Moreno, María Milagros; Oteo, José A.; Molina Romero, Israel (BMC, 2022-04-21)

Olmutinib in T790M-positive non–small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study

Park, Keunchil; Jӓnne, Pasi A.; Kim, Dong-Wan; Han, Ji-Youn; Wu, Ming-Fang; Lee, Jong-Seok; Felip Font, Enriqueta (Wiley, 2021-05-01)

On the clinical relevance of using complete high-resolution HLA typing for an accurate interpretation of posttransplant immune-mediated graft outcomes

Meneghini, Maria Antonia Emilia; Perona, Anna; Crespo Gimeno, Elena Isabel; Bemelman, Frederike; Reinke, Petra; Viklicky, Ondrej; Torija Recasens, Alba; Donadeu Casassas, Laura; Zuñiga-Vergara, Jose-Miguel; Bestard Matamoros, Oriol (Frontiers Media, 2022-09-29)

On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome

Huerta, Ana; Arjona, Emi; Portoles, Jose; Lopez-Sanchez, Paula; Cavero Escribano, Teresa; Fernández Cusicanqui, Jeanette Nora; Sellarés Roig, Joana; Ramos Terrades, Natalia (Elsevier, 2023-10)

ONCOS-102 plus pemetrexed and platinum chemotherapy in malignant pleural mesothelioma: a randomized phase 2 study investigating clinical outcomes and the tumor microenvironment

Ricordel, Charles; Isambert, Nicolas; Herrera-Juárez, Mercedes ; Martinez Marti, Alexandre; Ponce Aix, Santiago; cedres, susana; Viteri, Santiago; NAVARRO, ALEJANDRO; Serres-Créixams, Xavier (BMJ, 2023-09)

One-shot domain adaptation in multiple sclerosis lesion segmentation using convolutional neural networks

Valverde, Sergi; Salem, Mostafa; Cabezas Grebol, Mariano; Pareto Onghena, Deborah; Vilanova, Joan C; Ramió-Torrentà, Lluís; Rovira Cañellas, Alex (Elsevier, 2019)

One-year cardiovascular outcomes after coronavirus disease 2019: The cardiovascular COVID-19 registry

Ortega-Paz, Luis; Arévalos, Victor; Fernández-Rodríguez, Diego; Jiménez Díaz, Victor Alfonso; Bañeras Rius, Jordi; Campo, Gianluca (Public Library of Science, 2022-12-30)

One-year efficacy and safety of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: KYONAL study

Beato Zambrano, Carmen; Cabezón-Gutiérrez, Luis; CHICAS-SETT, RODOLFO; García Navalón, Francisco Javier; cobo, manuel; Blancas, Isabel; Giraldo Marin, Alexandra (BMJ, 2023-11)

Onset of efficacy and adverse events during Cenobamate titration period

Steinhoff, Bernhard; Ben-Menachem, Elinor; Brandt, Christian; García Morales, Irene; Rosenfeld, William; Santamarina Pérez, Estevo; Serratosa, José M. (Wiley, 2022-09)

Open reduction and polyaxial plating for stemmed knee periprosthetic fractures: A case series

González-Morgado, Diego; Nomdedeu Sancho, Josep; Tomás Hernández, Jordi; Andrés Peiró, José Vicente; Selga Marsa, Jordi; Piedra Calle, Carlos Alberto; Teixidor Serra, Jordi (EDP Open, 2023)

Open-access quantitative MRI data of the spinal cord and reproducibility across participants, sites and manufacturers

Cohen-Adad, Julien; Alonso-Ortiz, Eva; Abramovic, Mihael; Arneitz, Carina; Atcheson, Nicole; Barlow, Laura; Pareto Onghena, Deborah; Rovira Cañellas, Alex; Grussu, Francesco (Nature Research, 2021-08-16)

Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma

McDermott, David F.; Lee, Jae-Lyun; Ziobro, Marek; Suárez Rodríguez, Cristina; Langiewicz, Przemyslaw; Matveev, Vsevolod Borisovich (American Society of Clinical Oncology, 2021-03-20)

Opinion paper on the diagnosis and treatment of progressive familial intrahepatic cholestasis

McKiernan, Patrick; quintero, jesus; GIrard, Muriel; Indolfi, Giuseppe; Lurz, Eberhard; Trivedi, Palak (Elsevier, 2024-01)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Visualitzant HVH - Articles científics per títol

Observational study on fluid therapy management in surgical adult patients

Occupational radiation exposure of electrophysiology staff with reproductive potential and during pregnancy: an EHRA survey

Ocrelizumab exposure in relapsing–remitting multiple sclerosis: 10-year analysis of the phase 2 randomized clinical trial and its extension

Off-Label Use of Rituximab in Patients with Different Types of Nephropathies in a Tertiary Hospital: A Retrospective Study

Off-label use of rituximab in patients with systemic lupus erythematosus with extrarenal disease activity: a retrospective study and literature review

Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study)

Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis

Old zoonotic agents and novel variants of tick-borne microorganisms from Benguela (Angola), July 2017

Olmutinib in T790M-positive non–small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study

On the clinical relevance of using complete high-resolution HLA typing for an accurate interpretation of posttransplant immune-mediated graft outcomes

On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome

ONCOS-102 plus pemetrexed and platinum chemotherapy in malignant pleural mesothelioma: a randomized phase 2 study investigating clinical outcomes and the tumor microenvironment

One-shot domain adaptation in multiple sclerosis lesion segmentation using convolutional neural networks

One-year cardiovascular outcomes after coronavirus disease 2019: The cardiovascular COVID-19 registry

One-year efficacy and safety of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: KYONAL study

Onset of efficacy and adverse events during Cenobamate titration period

Open reduction and polyaxial plating for stemmed knee periprosthetic fractures: A case series

Open-access quantitative MRI data of the spinal cord and reproducibility across participants, sites and manufacturers

Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma

Opinion paper on the diagnosis and treatment of progressive familial intrahepatic cholestasis

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

Visualitzant HVH - Articles científics per títol

Observational study on fluid therapy management in surgical adult patients ﻿

Occupational radiation exposure of electrophysiology staff with reproductive potential and during pregnancy: an EHRA survey ﻿

Ocrelizumab exposure in relapsing–remitting multiple sclerosis: 10-year analysis of the phase 2 randomized clinical trial and its extension ﻿

Off-Label Use of Rituximab in Patients with Different Types of Nephropathies in a Tertiary Hospital: A Retrospective Study ﻿

Off-label use of rituximab in patients with systemic lupus erythematosus with extrarenal disease activity: a retrospective study and literature review ﻿

Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study) ﻿

Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis ﻿

Old zoonotic agents and novel variants of tick-borne microorganisms from Benguela (Angola), July 2017 ﻿

Olmutinib in T790M-positive non–small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study ﻿

On the clinical relevance of using complete high-resolution HLA typing for an accurate interpretation of posttransplant immune-mediated graft outcomes ﻿

On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome ﻿

ONCOS-102 plus pemetrexed and platinum chemotherapy in malignant pleural mesothelioma: a randomized phase 2 study investigating clinical outcomes and the tumor microenvironment ﻿

One-shot domain adaptation in multiple sclerosis lesion segmentation using convolutional neural networks ﻿

One-year cardiovascular outcomes after coronavirus disease 2019: The cardiovascular COVID-19 registry ﻿

One-year efficacy and safety of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: KYONAL study ﻿

Onset of efficacy and adverse events during Cenobamate titration period ﻿

Open reduction and polyaxial plating for stemmed knee periprosthetic fractures: A case series ﻿

Open-access quantitative MRI data of the spinal cord and reproducibility across participants, sites and manufacturers ﻿

Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma ﻿

Opinion paper on the diagnosis and treatment of progressive familial intrahepatic cholestasis ﻿

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

Observational study on fluid therapy management in surgical adult patients

Occupational radiation exposure of electrophysiology staff with reproductive potential and during pregnancy: an EHRA survey

Ocrelizumab exposure in relapsing–remitting multiple sclerosis: 10-year analysis of the phase 2 randomized clinical trial and its extension

Off-Label Use of Rituximab in Patients with Different Types of Nephropathies in a Tertiary Hospital: A Retrospective Study

Off-label use of rituximab in patients with systemic lupus erythematosus with extrarenal disease activity: a retrospective study and literature review

Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study)

Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis

Old zoonotic agents and novel variants of tick-borne microorganisms from Benguela (Angola), July 2017

Olmutinib in T790M-positive non–small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study

On the clinical relevance of using complete high-resolution HLA typing for an accurate interpretation of posttransplant immune-mediated graft outcomes

On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome

ONCOS-102 plus pemetrexed and platinum chemotherapy in malignant pleural mesothelioma: a randomized phase 2 study investigating clinical outcomes and the tumor microenvironment

One-shot domain adaptation in multiple sclerosis lesion segmentation using convolutional neural networks

One-year cardiovascular outcomes after coronavirus disease 2019: The cardiovascular COVID-19 registry

One-year efficacy and safety of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: KYONAL study

Onset of efficacy and adverse events during Cenobamate titration period

Open reduction and polyaxial plating for stemmed knee periprosthetic fractures: A case series

Open-access quantitative MRI data of the spinal cord and reproducibility across participants, sites and manufacturers

Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma

Opinion paper on the diagnosis and treatment of progressive familial intrahepatic cholestasis